Altered ocular surface immune cell profile in patients with dry eye disease.

Dry eye disease Flow cytometry Immune cells Immunophenotyping Natural killer cells Neutrophils T cells

Journal

The ocular surface
ISSN: 1937-5913
Titre abrégé: Ocul Surf
Pays: United States
ID NLM: 101156063

Informations de publication

Date de publication:
07 2021
Historique:
received: 18 02 2021
revised: 06 04 2021
accepted: 06 04 2021
pubmed: 17 4 2021
medline: 29 9 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Aberrant inflammation and immune dysregulation are known pathogenic contributors in dry eye disease (DED). Aim of the study was to determine the proportions of immune cell subsets on the ocular surface (OS) of DED patients. 15 healthy controls (22 eyes) and 48 DED subjects (36 eyes with evaporative DED - EDED; 60 eyes with aqueous deficient DED - ADED) were included in the study. Tear break up time (TBUT), Schirmer's test 1 (ST1), corneal staining (CS) and ocular surface disease index (OSDI) scoring were recorded. OS wash was used to collect immune cells on the OS of study subjects. The cells immunophenotyped using flow cytometry include leukocytes, neutrophils, macrophages, natural killer-NK cells and T cell subsets (CD4; CD8; double positive-DP; gamma delta-γδ and NK T cells). Significantly higher proportions of leukocytes, neutrophils, CD4 T cells, CD8 T cells, DP T cells and CD4/CD8 T cells ratio were observed in EDED and/or ADED patients. Significantly higher proportions of neutrophils and lower proportions of NK cells were observed in ADED subjects with corneal staining compared to those without and controls. Neutrophils/NK cells ratio was significantly higher in EDED and ADED subjects compared to controls. Correlation analysis revealed pathological relationships between proportions of leukocytes, neutrophils, CD4 T cells and Neutrophil/NK cells ratio with DED clinical parameters. OS immune cell subset proportion changes in DED patients were associated with DED types and severity. The data suggests the potential for a new generation of therapies targeting immune cells on the ocular surface.

Identifiants

pubmed: 33862224
pii: S1542-0124(21)00030-6
doi: 10.1016/j.jtos.2021.04.002
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-106

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Archana Padmanabhan Nair (AP)

GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India; Manipal Academy of Higher Education, Manipal, India.

Sharon D'Souza (S)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Rohit Shetty (R)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Prerna Ahuja (P)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Gairik Kundu (G)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Pooja Khamar (P)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Zelda Dadachanji (Z)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Prajakta Paritekar (P)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Pavitra Patel (P)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.

Mor M Dickman (MM)

University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands; MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands.

Rudy Mma Nuijts (RM)

University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.

Rajiv R Mohan (RR)

Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, USA; Harry S Truman Veterans' Memorial Hospital, Columbia, MO, USA. Electronic address: mohanr@health.missouri.edu.

Arkasubhra Ghosh (A)

GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India; Singapore Eye Research Institute, Singapore. Electronic address: arkasubhra@narayananethralaya.com.

Swaminathan Sethu (S)

GROW Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India. Electronic address: swaminathansethu@narayananethralaya.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH